Acer Therapeutics is a pharmaceutical company that focuses on the acquisition, development, and commercialization of therapies for serious, rare, and life-threatening diseases with unmet medical needs. Its pipeline includes four clinical-stage candidates: emetine hydrochloride for the treatment of patients with COVID-19; ACER-001 (a taste-masked, immediate-release formulation of sodium phenylbutyrate), for the treatment of various inborn errors of metabolism, including urea cycle disorders (UCDs) and Maple Syrup Urine Disease (MSUD); EDSIVO (celiprolol), for the treatment of vascular Ehlers-Danlos syndrome (vEDS) in patients with a confirmed type III collagen (COL3A1) mutation; and osanetant, for the treatment of induced Vasomotor Symptoms (iVMS). The company was founded in 2013 and is headquartered in Newton, Massachusetts.

Prilenia Therapeutics Development Ltd., a subsidiary of Prilenia Therapeutics BV, is a company headquartered in Herzliya, Israel. The firm operates clinical stage biotech company. It was founded by Michael R. Hayden.\nThe company says this about itself: Prilenia is a clinical stage biotech startup founded in 2018 with the purpose of improving the lives of patients and their families by developing treatments for neurodegenerative and neurodevelopmental disorders. Prilenia is based in Naarden, the Netherlands and Herzliya, Israel.

Zhaoke Pharmaceutical (Guangzhou) Ltd., a subsidiary of Lee's Pharmaceutical Holdings Ltd., is a company headquartered in Guangzhou, China, that manufactures and sells pharmaceutical products.

Sunshine Lake Pharma Co. Ltd., a subsidiary of Shenzhen Dongyangguang Industry Co., Ltd., is a Chinese company. The firm manufactures and supplies pharmaceutical ingredients and drugs. Wen Jia Li has been the CEO since 2021. On December 23, 2022 Shenzhen Dongyangguang Industry Co., Ltd. acquired Sunshine Lake Pharma Co. Ltd. from YiChang HEC ChangJiang Pharmaceutical Co., Ltd. for $330.99 million.

Hangzhou Aiming Medical Technology Co. Ltd. is a Chinese company that manufactures and supplies medical related products.

The USC Incubator accelerates the development of USC’s top student and alumni entrepreneurs through experiential education, mentorship and community. The USC Incubator, supported by the Greif Center for Entrepreneurial Studies at USC’s Marshall School takes founders from feasibility and development work, on to customers, a tested business model, getting distribution, building a team, bootstrapping and investment preparation. They also provide access to other supporting resources, such as legal and financial assistance.

LG H&H Co., Ltd. engages in the production and sale of household goods and cosmetic products. It operates through following divisions Beauty, Health and Refreshment businesses. The Beauty business division provides anti-aging cosmetic products. The Health division markets healthcare, skincare and household products. The Refreshment division provides soda, juice, energy drinks and other beverages. The company was founded on April 3, 2001 and is headquartered in Seoul, South Korea.

Beijing Hengrui Kangda Pharmaceutical Technology Development Co., Ltd., established on 2004-09-01, Business scope includes technical consulting,technology development,technology transfer;sell cosmetics,Chemical Products(Does not contain dangerous chemicals and a class of precursor chemicals),Equipment,Wujinjiaodian,stationery,sporting goods,daily necessities,household appliances,building materials(Not engaged in physical store operation);Undertake exhibition and display activities;Prepackaged food sales(Does not contain refrigerated frozen food)(The food distribution license is valid until2023year03moon01day).(Enterprises independently choose operating projects according to law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the city's industrial policies.)

Zhaoke Pharmaceutical (Hefei) Co., Ltd., established on 1994-02-07, Business scope includes licensed projects:pharmaceutical production;Drug Wholesale;Drug retail;Drug import and export;Disinfectant production(Free of Hazardous Chemicals);Class III medical device business(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Disinfectant sales(Free of Hazardous Chemicals);Sales of Class I Medical Devices;Sales of Class II Medical Devices(Except for licensed business,Can independently operate projects that are not prohibited or restricted by laws and regulations)

Weihai Civic Information Technology Co., Ltd., established on 2014-08-22, Business scope includes general items:software development;Software outsourcing service;Information Technology Consulting Services;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Medical Need Europe AB is a self financed and privately owned company. The headquarters are located right in the center of Stockholm, Sweden and the company is incorporated under Swedish law. In Stockholm central functions like medical affairs, logistics, regulatory affairs, pharmacovigilance, customer service, partnership development, marketing, management and finance is located. Our mission is to provide niche pharmaceuticals for patients with special needs or for specific situations in health care. We aim to satisfy unmet medical needs for patients and caregivers in Europe. We strive to offer high quality services for the benefit of both patients, customers, payers and partners to meet their needs and secure access to smaller specialty products for patients with rare disorders.

Jiangsu Yongan Pharmaceutical Co., Ltd., established on 2006-03-29, Business scope includes licensed projects:pharmaceutical production;Drug import and export;Import and export;Import and export agency;Technology Import and Export;Health food production;Production of formula food for special medical purpose;Health food sales;Cosmetic production;Pharmaceutical commissioned production(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Information Consulting Service(Not including licensing information consulting services);Sales of Class I Medical Devices;Production of Class I Medical Devices;Chemical product production(No licensed chemical products);Chemical product sales(No licensed chemical products);Sales of hygiene products and single-use medical products;internet sales(Except for products that require a license for sale);Production of protective equipment for medical personnel(Ι class medical device)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

The United States Department of Veterans Affairs (VA) is a federal Cabinet-level agency that provides near-comprehensive healthcare services to eligible military veterans at VA medical centers and outpatient clinics located throughout the country; several non-healthcare benefits including disability compensation, vocational rehabilitation, education assistance, home loans, and life insurance; and provides burial and memorial benefits to eligible veterans and family members at 135 national cemeteries.

Amylyx Pharmaceuticals, Inc. operates as a biopharmaceutical company, which engages in the provision of disease-modifying solutions for neurodegenerative diseases. The company was founded by Joshua Cohen and Justin Klee in 2013 and is headquartered in Cambridge, MA.

Proyecto de Biomedicina CIMA SL is a holding company engaged in the provision of product licensing and intellectual property rights management services. It holds patents generated by the Centro de Investigacion Medica Aplicada, which have indications across the clinical fields of oncology, hepatology, dermatology, and gene therapy. The company was founded in June 2003 and is headquartered in Pamplona, Spain.

UCLB is the commercialisation company of UCL and its partner NHS Trusts. They bring to market truly world-leading, world-changing technologies, innovations that have a real and positive impact on people’s lives. UCLB the access point to the wealth of innovation and intellectual property emanating from UCL and partner hospitals including University College Hospital, Great Ormond Street Hospital, Royal Free Hospital and Moorfields Eye Hospital. They offer a number of services to assist the technology development process, from consultancy through to collaborative research, IP licensing and the creation of spinout companies and joint ventures to maximise the commercial potential of new discoveries, materials and processes.

SeQuent Scientific Limited is an India-based integrated pharmaceutical company. The Company engaged in developing products and services for a variety of industries, such as pharmaceuticals, agrochemicals, plastics, personal care (cosmetics). The Company operates in three segments include active pharmaceutical ingredients (API), Analytical Services and Animal Health. The Company’s products range from APIs and pharmaceutical intermediates to phyto chemicals and specialty chemicals for industrial use and research. The Company's APIs in human health sector include Albendazole, Lumefantrine, Midazolam, Artesunate, Imiquimod and Miconazole Nitrate, among others. The Company’s APIs in animal health include Albendazole, Buparavaquone, Butaphosphan and Nitroscanate, among others.

Beijing Sun-Novo Pharmaceutical Research Co., Ltd. engages in the research and development of pharmaceutical products. It mainly focuses on generic and innovative drug research and offers chemical drugs and peptide drugs. The company also provides preclinical and clinical drug development services. Beijing Sun-Novo Pharmaceutical Research was founded on March 9, 2009 and is headquartered in Beijing, China.

Beijing Baiao Pharmaceuticals Co., Ltd. engages in the production, research and development of pharmaceutical products. It offers lumbrokinase, a prescription drug which is used to treat cardio cerebrovascular diseases. The company was founded on January 19, 1995 and is headquartered in Beijing, China.